News & Events about Alpha Tau Medical Ltd Cl A.
JERUSALEM, Dec. 13, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau," or the Company), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, announced today that the Company plans to present at the Biotech Showcase and host institutional ...
Globe Newswire
2 months ago
JERUSALEM, Nov. 09, 2022 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. (Nasdaq: DRTS, DRTSW) ("Alpha Tau", or the Company), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, today announced the Company will present in person at the following investor conferences in November: ...
Globe Newswire
5 months ago
JERUSALEM and CLEVELAND, Aug. 22, 2022 (GLOBE NEWSWIRE) -- Today, Alpha Tau Medical Ltd. (Nasdaq: DRTS) ("Alpha Tau"), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT, and MIM Software Inc. (MIM Software), a leading global provider of medical imaging software, announced a ...
Ticker Report
6 months ago
Alpha Tau Medical Ltd. (NASDAQ:DRTS Get Rating)s share price gapped up before the market opened on Monday . The stock had previously closed at $10.28, but opened at $10.75. Alpha Tau Medical shares last traded at $10.95, with a volume of 793 shares. Analysts Set New Price Targets ...
Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT in Recurrent Cutaneous SCC Alpha Tau Announces FDA Approval of IDE to Initiate Multi-Center Pivotal Study of Alpha DaRT in Recurrent Cutaneous SCC PR Newswire JERUSALEM, June 8, 2022 JERUSALEM, June 8, 2022...